Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 12:32PM ET
9.70
Dollar change
+0.20
Percentage change
2.11
%
Index- P/E- EPS (ttm)-2.45 Insider Own3.93% Shs Outstand41.10M Perf Week-0.61%
Market Cap273.15M Forward P/E- EPS next Y-1.47 Insider Trans-4.22% Shs Float27.06M Perf Month81.31%
Income-95.73M PEG- EPS next Q-0.42 Inst Own61.38% Short Float21.68% Perf Quarter155.94%
Sales0.00M P/S- EPS this Y36.53% Inst Trans- Short Ratio3.06 Perf Half Y175.57%
Book/sh1.90 P/B5.10 EPS next Y5.07% ROA-65.01% Short Interest5.87M Perf Year239.16%
Cash/sh3.54 P/C2.74 EPS next 5Y- ROE-83.59% 52W Range2.41 - 11.10 Perf YTD165.03%
Dividend Est.- P/FCF- EPS past 5Y2.29% ROI-103.76% 52W High-12.61% Beta-6.98
Dividend TTM- Quick Ratio3.22 Sales past 5Y0.00% Gross Margin- 52W Low302.49% ATR (14)0.96
Dividend Ex-Date- Current Ratio3.22 EPS Y/Y TTM-25.82% Oper. Margin0.00% RSI (14)63.98 Volatility10.47% 14.13%
Employees57 Debt/Eq0.18 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price32.67
Option/ShortYes / Yes LT Debt/Eq0.18 EPS Q/Q-358.87% Payout- Rel Volume1.15 Prev Close9.50
Sales Surprise- EPS Surprise-25.30% Sales Q/Q- EarningsFeb 28 BMO Avg Volume1.92M Price9.70
SMA2014.26% SMA5062.43% SMA200131.88% Trades Volume1,091,972 Change2.11%
Date Action Analyst Rating Change Price Target Change
Dec-05-23Initiated Canaccord Genuity Buy $9
Dec-09-22Resumed ROTH Capital Buy $25
Nov-16-22Initiated RBC Capital Mkts Outperform $5
Aug-26-22Initiated Oppenheimer Outperform $3.50
Aug-10-22Initiated Cantor Fitzgerald Overweight $3
May-04-22Initiated ROTH Capital Buy $7
Jun-28-21Initiated Maxim Group Buy $6
Mar-19-24 08:00AM
Mar-11-24 07:00AM
Mar-10-24 11:10AM
Mar-08-24 10:46AM
07:00AM
07:13AM Loading…
Mar-07-24 07:13AM
06:00AM
Mar-01-24 09:00AM
Feb-28-24 07:05AM
Feb-22-24 07:00AM
Feb-07-24 07:00AM
Jan-24-24 09:00AM
Jan-08-24 12:27PM
07:45AM
Dec-17-23 05:49PM
07:30AM Loading…
Dec-14-23 07:30AM
Dec-11-23 12:19PM
Nov-02-23 04:01PM
Oct-30-23 12:11PM
Oct-26-23 07:30AM
Oct-24-23 07:30AM
Oct-03-23 07:30AM
Sep-14-23 07:30AM
Sep-12-23 07:30AM
Aug-28-23 07:30AM
Aug-14-23 07:30AM
Aug-03-23 04:01PM
07:30AM
Jul-31-23 08:30AM
Jun-22-23 08:42AM
08:30AM Loading…
08:30AM
Jun-21-23 12:08PM
Jun-20-23 08:30AM
Jun-15-23 04:23PM
10:45AM
Jun-09-23 09:00AM
Jun-08-23 11:30AM
Jun-07-23 08:07AM
08:00AM
Jun-05-23 08:00AM
07:00AM
Jun-02-23 04:17PM
Jun-01-23 07:00AM
May-30-23 04:17PM
May-25-23 04:57PM
04:00PM
08:00AM
May-24-23 07:00AM
May-17-23 04:01PM
May-15-23 08:24AM
May-05-23 08:08AM
May-04-23 04:02PM
May-02-23 08:00AM
May-01-23 04:01PM
Apr-26-23 07:00AM
Apr-21-23 08:22AM
Apr-18-23 04:15PM
Apr-14-23 07:00AM
Apr-13-23 07:00AM
Mar-09-23 04:02PM
Feb-28-23 07:30AM
Feb-16-23 03:45PM
Jan-17-23 05:00AM
Jan-09-23 07:30AM
Dec-01-22 07:30AM
Nov-14-22 08:08AM
Nov-11-22 07:30AM
Nov-10-22 08:05AM
Nov-03-22 08:08AM
07:30AM
Oct-05-22 08:35AM
Oct-04-22 07:30AM
Sep-28-22 03:51PM
08:14AM
Sep-27-22 11:47PM
06:27PM
05:06PM
04:17PM
Sep-20-22 07:30AM
Sep-14-22 07:30AM
Sep-12-22 07:00AM
Sep-08-22 07:30AM
Sep-07-22 07:30AM
Aug-26-22 04:30PM
Aug-25-22 07:30AM
Aug-23-22 09:59AM
09:50AM
Aug-17-22 10:49PM
Aug-12-22 07:30AM
Aug-11-22 04:06PM
08:08AM
Aug-04-22 05:30PM
07:30AM
Aug-02-22 07:30AM
Jun-30-22 05:30PM
Jun-01-22 05:30PM
07:59AM
May-26-22 12:09PM
May-23-22 07:30AM
May-19-22 07:30AM
Mind Medicine (MindMed), Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn in 2019 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Barrow RobertChief Executive OfficerMar 25 '24Sale9.5016,519156,930580,202Mar 26 05:15 PM
Karlin DanChief Medical OfficerMar 25 '24Sale9.506,57862,491358,452Mar 26 05:15 PM
Barrow RobertChief Executive OfficerDec 26 '23Sale3.6313,23748,050596,721Dec 26 04:50 PM
Karlin DanChief Medical OfficerDec 26 '23Sale3.636,77424,590365,030Dec 26 04:59 PM
Greenway Schond L.Chief Financial OfficerDec 26 '23Sale3.635,65220,517216,617Dec 26 04:44 PM
Barrow RobertChief Executive OfficerSep 25 '23Sale3.5813,49948,274611,729Sep 25 09:30 PM
Karlin DanChief Medical OfficerSep 25 '23Sale3.576,91824,730371,804Sep 25 09:30 PM
Greenway Schond L.Chief Financial OfficerSep 25 '23Sale3.585,76220,609222,269Sep 25 09:30 PM
Greenway Schond L.Chief Financial OfficerAug 25 '23Sale3.8020,00076,000228,031Aug 28 08:01 PM
Barrow RobertChief Executive OfficerJun 27 '23Sale3.2015,50249,620623,457Jun 27 07:41 PM
Greenway Schond L.Chief Financial OfficerJun 27 '23Sale3.2011,63537,194248,031Jun 27 06:53 PM
Karlin DanChief Medical OfficerJun 27 '23Sale3.206,78321,697378,722Jun 27 07:00 PM